April 13, 2021, Vol 325, No. 14, Pages 1369-1480
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19A Randomized Clinical Trial
Eduardo López-Medina, MD, MSc; Pío López, MD; Isabel C. Hurtado, MD; et al.
free access has active quiz
JAMA. 2021;325(14):1426-1435. doi:10.1001/jama.2021.3071
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.